Nov 10, 2016 Cellectar Biosciences Announces Recent Key Accomplishments and Third Quarter 2016 Financial Results Learn More
Nov 7, 2016 Cellectar Biosciences to Host Conference Call on November 11 to Report Third Quarter 2016 Financial Results and Corporate Performance Learn More
Oct 31, 2016 Cellectar Biosciences Announces Design for NCI-Supported Phase II Study of CLR 131 in Multiple Myeloma and Other Hematologic Malignancies Learn More
Oct 24, 2016 Cellectar Biosciences Announces Data on CLR 131 Accepted For Poster Presentation at the 58th Annual American Society of Hematology Meeting & Exposition Learn More